Fig. 2From: PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitorsPD-L1 in tumor and inflammatory cells and p53 immunostaining. a PD-L1 in tumor vs inflammatory cells, b PD-L1 in tumor cells vs p53, and c PD-L1 in inflammatory cells vs p53Back to article page